Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

27,705 signal articles · 237 in last 24h · 134,276 total before filter · latest 30m ago
237last 24h
1111last 7d
179● bullish (7d)
133● bearish (7d)
209publishers
AllMacro294Earnings370M&A76Regulatory27Product11Analyst15
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Viavi Solutions EVP Sells 1,595 Shares for $60,000
Motley Fool23d agobearish
Viavi Solutions EVP Sells 1,595 Shares for $60,000

Paul McNab trimmed his direct equity stake by 10% while the stock maintains a 240% annual gain. The sale price of $37.37 exceeded the day's market close, suggesting strong execution amid sustained momentum.

RIOT Stocks Path to 71.21% Upside This Year
24/7 Wall St.23d agoneutral
RIOT Stocks Path to 71.21% Upside This Year

Riot Platforms has already handed long-term holders a massive year-to-date gain, yet Wall Street analysts and a proprietary model are pointing to a target that would still more than double the current share price. The question is whether three very specific conditions can fall into place before 2026 ends.

Salesforce (CRM) Lost A Major Healthcare Customer To An In House AI CRM
Simply Wall St.23d agoneutral
Salesforce (CRM) Lost A Major Healthcare Customer To An In House AI CRM

Curative ends a major Salesforce (NYSE:CRM) contract and rolls out its own in-house, AI-powered CRM platform for healthcare operations. The company cites cost and speed advantages from its internal system compared with Salesforce's tools. Salesforce responds by highlighting ongoing security and compliance challenges for AI driven platforms in regulated sectors such as healthcare. The move raises fresh questions for investors about how generative AI could affect traditional SaaS models and...